Solid water-soluble aluminum phosphate complexes and binder composition which dissolve in water to give solutions containing aluminum ions and orthophosphate ions in such proportions as to provide an Al:P ratio of substantially 1:1 together with the anions of a carboxylic acid or a mineral oxyacid.

A composition comprising a nitroprusside of a short acting ganglionic blocking agent selected from the group consisting of sulfonium salts and ammonium salts.

A compound of vanadium or niobium complexed with NO and a selected complexing agent.

A novel anthracycline antibiotic complex designated herein as figaroic acid complex is produced by fermentation of Streptosporangium sp. strain C-31,751, A.T.C.C. 31129. Figaroic acid complex inhibits the growth of various microorganisms, e.g., Staphylococcus aureus, exhibits phage inducing properties and inhibits the growth of various tumors in rodents, e.g., Sarcoma 180, L-1210 lymphatic leukemia, B-16 melanoma, Walker 256 carcinosarcoma and P-388 lymphatic leukemia.

A novel aminoglycoside antibiotic complex designated herein as Bu-2183 is produced by fermentation of Pseudomonas sp. strain D946-B83, A.T.C.C. 31086. Complex Bu-2183 is known to consist of at least five components, said components being herein designated Bu-2183 A, A.sub.2, B, C and D. The complex and the individual aminoglycoside components Bu-2183 A, A.sub.2, and B are found to have a broad spectrum of antibacterial activity and are especially useful in inhibiting aminoglycoside-resistant org...

The invention relates to an immunogenic complex comprising at a least one glycoside and at least one lipid, integrated into an iscom complex or matrix, and at least one antigen which antigen is integrated into the iscom complex or coupled on to or mixed with the iscom complex or iscom matrix complex, characterised in that it also comprises at least one enzyme. It also relates to such a complex further comprising at least one peptide which specifically binds to a receptor expressed on a cell capa...

A sports or stadium complex having movable stands to define different playing fields for different sports with stands substantially surrounding same is provided. The sports complex includes a plurality of stationary stands, and a second plurality of movable stands, each of said movable stands being adapted to move from a first position wherein each of said stationary stands and said movable stands are positioned with respect to each other to define a first playing field with stands substantially...

The present invention relates to a ruthenium complex, represented by the following formula (I): RuLL'X.sub.2 (I) wherein L, L' and X are defined the same as the specification. The ruthenium complex of the present invention is suitable for Dye-Sensitized Solar Cell (DSSC) and has good photoelectric characteristics.

Monocyclopentadienyl complexes in which the cyclopentadienyl system bears at least one unsubstituted, substituted or fused, heteroaromatic ring system bound via a specific bridge, a catalyst system, comprising at least one of these monocyclopentadienyl complexes, the use of the catalyst system for the polymerization or copolymerization of olefins and a process for preparing polyolefins by polymerization or copolymerization of olefins in the presence of the catalyst system and polymers obtainable...

A drug complex characterized in that a residue of a drug compound such as antineoplastic agents and a carboxy(C.sub.1-4)alkyldextran polyalcohol obtained by treating a dextran under conditions that enable substantially complete polyalcoholization are bound to each other by means of a spacer comprising an amino acid or a spacer comprising peptide-bonded 2 to 8 amino acids. Said complex is characterized in that it has excellent selectivity to tumorous sites so as to exhibit high antineoplastic act...